Gentian Diagnostics to attend AAVLD/USAHA annual meeting, showcase canine CRP immunoassay
Bitget2026/10/08 10:51Gentian Diagnostics will attend the AAVLD/USAHA Annual Meeting in Madison, Wisconsin, in October 2026. Plans to showcase its Canine CRP Immunoassay for quantitative canine C-reactive protein testing on routine clinical chemistry analyzers. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Gentian Diagnostics ASA published the original content used to generate this news brief on October 08, 2026, and is solely responsible for the information contained therein.
- Gentian Diagnostics will attend the AAVLD/USAHA Annual Meeting in Madison, Wisconsin, in October 2026.
- Plans to showcase its Canine CRP Immunoassay for quantitative canine C-reactive protein testing on routine clinical chemistry analyzers.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Canaccord Genuity: Lowers Oklo's target price to $66
"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.
Dental treatment company vVardis has announced the terms for its $214 million US IPO.
Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss
Novo Nordisk reports that some patients treated with Wegovy have shown improvements in liver conditions.
Crypto prices
More
